In addition, B cells present tumor-specific antigens via MHCII to Th cells inducing their anti-tumor effector function and they also regulate the immune response within the TME through the release of cytokines, such as IFN-γ, IL-12, or IL-10 (32, 33). Here, IFNG is linked to neoplasm.